BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Biocon (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Total Share Capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Reserves and Surplus | 3,169.70 | 2,925.80 | 2,593.70 | 2,171.50 | 1,931.90 | |
| Total Reserves and Surplus | 3,170.60 | 2,926.70 | 2,594.60 | 2,172.40 | 1,932.80 | |
| Total Shareholders Funds | 3,270.60 | 3,026.70 | 2,694.60 | 2,272.40 | 2,032.80 | |
| Minority Interest | 172.20 | 82.30 | 65.30 | 3.80 | 37.70 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 769.60 | 606.20 | 164.00 | 69.80 | 65.80 | |
| Deferred Tax Liabilities [Net] | 41.70 | 45.00 | 41.20 | 0.00 | 49.70 | |
| Other Long Term Liabilities | 551.60 | 603.00 | 423.70 | 583.20 | 339.00 | |
| Long Term Provisions | 15.00 | 7.80 | 4.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1,377.90 | 1,262.00 | 632.90 | 653.00 | 454.50 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 261.00 | 243.50 | 84.80 | 187.30 | 247.40 | |
| Trade Payables | 429.30 | 347.20 | 345.50 | 347.80 | 296.50 | |
| Other Current Liabilities | 706.20 | 612.30 | 346.50 | 269.20 | 375.90 | |
| Short Term Provisions | 158.20 | 176.60 | 246.50 | 211.50 | 140.80 | |
| Total Current Liabilities | 1,554.70 | 1,379.60 | 1,023.30 | 1,015.80 | 1,060.60 | |
| Total Capital And Liabilities | 6,375.40 | 5,750.60 | 4,416.10 | 3,945.00 | 3,585.60 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,580.70 | 1,503.50 | 1,488.40 | 1,250.20 | 1,177.00 | |
| Intangible Assets | 49.20 | 21.70 | 21.90 | 20.30 | 139.20 | |
| Capital Work-In-Progress | 1,493.80 | 1,083.10 | 205.40 | 286.30 | 166.90 | |
| Fixed Assets | 3,306.50 | 2,730.80 | 1,822.80 | 1,660.00 | 1,578.30 | |
| Non-Current Investments | 0.00 | 64.50 | 64.50 | 64.20 | 60.90 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 7.80 | 0.00 | |
| Long Term Loans And Advances | 369.30 | 269.30 | 248.30 | 184.60 | 139.20 | |
| Other Non-Current Assets | 137.00 | 47.20 | 40.50 | 28.70 | 0.00 | |
| Total Non-Current Assets | 3,812.80 | 3,111.80 | 2,176.10 | 1,945.30 | 1,778.40 | |
| CURRENT ASSETS | ||||||
| Current Investments | 230.30 | 700.40 | 522.10 | 492.10 | 399.50 | |
| Inventories | 452.70 | 376.60 | 398.40 | 378.30 | 413.70 | |
| Trade Receivables | 770.50 | 599.80 | 509.70 | 491.70 | 495.80 | |
| Cash And Cash Equivalents | 937.50 | 804.40 | 672.90 | 523.30 | 441.50 | |
| Short Term Loans And Advances | 81.30 | 81.80 | 81.40 | 77.40 | 40.00 | |
| OtherCurrentAssets | 90.30 | 75.80 | 55.50 | 36.90 | 16.70 | |
| Total Current Assets | 2,562.60 | 2,638.80 | 2,240.00 | 1,999.70 | 1,807.20 | |
| Total Assets | 6,375.40 | 5,750.60 | 4,416.10 | 3,945.00 | 3,585.60 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 711.60 | 752.70 | 935.40 | 442.40 | 347.90 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 93.47 | 93.47 | 93.47 | 93.47 | 93.47 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 159.90 | 117.60 | 97.80 | 153.80 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 21.80 | 21.80 | 34.90 | 34.90 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 230.30 | 700.40 | 522.10 | 492.10 | 399.50 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025